Disposable Syringes Market Size, Share & Trends Analysis Report By Syringe Type (Safety, Conventional), By End-use (Hospital, Outpatient Facilities), By Region (Middle East & Africa, North America), And Segment Forecasts, 2023 - 2030

Disposable Syringes Market Size, Share & Trends Analysis Report By Syringe Type (Safety, Conventional), By End-use (Hospital, Outpatient Facilities), By Region (Middle East & Africa, North America), And Segment Forecasts, 2023 - 2030

Disposable Syringes Market Growth & Trends

The global disposable syringes market size is expected to reach USD 22.81 billion by 2030, registering a CAGR of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by factors, such as a rise in technological advancements and a high incidence of obesity. Moreover, the increasing adoption of safety syringes and prevalence of diabetes drive market growth. Leading manufacturers are focusing on technological innovations and developing advanced products to gain substantial market shares. Increasing prevalence of chronic disorders, such as diabetes, can be managed by self-injecting medication. Growing cases of chronic diseases and a rising number of vaccinations that make extensive use of syringes, such as single-use and disposable syringes, are boosting market growth.

According to the International Diabetes Federation (IDF) Diabetics Atlas, the diabetic population is anticipated to grow by 46.0% reaching 643 million (1 in 9 adults) by 2030, and likely to majorly rise in middle-income countries, as compared to the developed countries. North America dominated the market in 2022 with a share of over 40%. MEA has the highest prevalence of diabetes in countries like Kuwait, Saudi Arabia, and Bahrain; thus, the region is anticipated to register the fastest CAGR of 6.9% from 2023 to 2030. Moreover, the presence of untapped opportunities in the emerging economies of Saudi Arabia and Kuwait will support regional market growth.

Disposable Syringes Market Report Highlights

• The conventional syringes segment accounted for the largest share of around 53% in 2022. The use of injection and auto-injectors comprises the use of needles. Conventional syringes are the most practiced and used syringes in homecare settings. For instance, B.D.’s conventional syringes and needles range, the conventional disposable syringes guarantee protection for the patient receiving it. Such factors are likely to drive segment growth
• The safety syringes segment is estimated to register the fastest CAGR of 6.4% from 2023 to 2030. Safety syringes are required for most diagnostic and therapeutic approaches for chronic diseases since they are essential during medication administration and tests, resulting in rising product demand. In 2019, Japanese firm Morimoto Pharma launched a S.A.F.E. Syringe Kit vial comprising pre-attached needle syringes and a tube-shaped container into an innovative synergistic design. Such innovations are expected to ease product usage for healthcare workers
• The hospital end-use segment accounted for the largest revenue share of over 50% in 2022 due to studies being meticulously designed to maximize the chances of detecting meaningful treatment. The demand for dispensing syringes in hospitals continues to rise. Prefilled and disposable syringes are becoming increasingly common in some European states due to the use of prefilled syringes in ICUs and operating theaters

Please note The report will be delivered in 2-3 business days upon order notification.